GoldenGolden
Advanced Search
Northern Light Venture Capital

Northern Light Venture Capital

A venture capital firm in China that focuses on early and growth stage opportunities in the information technology, new media, TMT, clean technologies, consumer service and healthcare sectors

Northern Light Venture Capital is a venture capital firm in China that focuses on early and growth stage opportunities in the information technology, new media, TMT, clean technologies, consumer service and healthcare sectors. Founded 2005 in Beijing, China by Feng Deng, Jeffrey Lee and Yan Ke, it invests in early stage ventures, late stage ventures, seed, series B, series A, series C, and series D rounds. Its portfolio companies include Hugo Biotech, Huaqin Communication Technology, XuetangX, ThreatBook, and Bominwell Robotics. As of February 2020, Northern Light Venture Capital has made 181 investments. Their most recent investment was on February 25, 2020, when Hugo Biotech raised CN¥100M. Northern Light Venture Capital has had 13 exits, the most notable of which include Meituan.com, Shape Security, and Drive.ai. The company has raised seven funds, their latest being Northern Light Strategic Fund V. This fund was announced on March 5, 2019 and raised a total of $445M.

Timeline

2005
Founded

Associated investment funds

People

Name
Role
LinkedIn

Feng Deng

Founding Managing Director

Elton Jiang

Managing Director

Jeffrey Lee

Managing Director & CFO

Lei Yang

Managing Director

Lixin Li

Managing Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Kangpu Bio-Pharma

AgotoZ Technology

Bominwell Robotics

Hugo Biotech

Huohua Siwei

LuxCreo

Micot

New Core Technology (Xinyunhe)

Qihan Biotech

Yunyinggu

News

Title
Author
Date
Publisher
Description
Teon Therapeutics, Inc.
February 23, 2021
www.prnewswire.com:443
/PRNewswire/ -- Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting signaling...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.